Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Anti-inflammatory properties of antidiabetic drugs: A “promised land” in the COVID-19 era?
Authors
Keywords
Metformin, Pioglitazone, Dipeptidyl peptidase 4 inhibitors, Glucagon-like peptide-1 receptor agonists, Sodium-glucose co-transporter-2 inhibitors, C-reactive protein, Interleukin 6, Ferritin
Journal
JOURNAL OF DIABETES AND ITS COMPLICATIONS
Volume -, Issue -, Pages 107723
Publisher
Elsevier BV
Online
2020-08-26
DOI
10.1016/j.jdiacomp.2020.107723

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.